Abstract 1584: Epidemiology of Hemorrhagic and Gastrointestinal Adverse Effects of Low-dose Aspirin for Primary Prevention of Atherosclerotic Events in Type 2 Diabetic Patients: Insights From JPAD TrialTakeshi Morimoto, Yoshihiko Saito, Hisao Ogawa et al.|Circulation|2009Cited by 1
Abstract 12166: Efficacy of Low-dose Aspirin Therapy for Primary Prevention of Atherosclerotic Events Depends on the Severity of Diabetes: a subanalysis of JPAD trialSadanori Okada, Yoshihiko Saito, Takeshi Morimoto et al.|Circulation|2010Cited by 0
Abstract 12906: Impact of Blood Pressure Control in Type 2 Diabetes Patients in Relation to Aspirin Therapy: Insight From the JPAD TrialHirofumi Soejima, Hisao Ogawa, Shiro Uemura et al.|Circulation|2010Cited by 0
Abstract 9385: Longer History of Diabetes Attenuates Benefit of Low-Dose Aspirin for Primary Prevention of Cardiovascular Events: A subanalysis from the JPAD TrialSadanori Okada, Takeshi Morimoto, Hisao Ogawa et al.|Circulation|2011Cited by 0
Abstract 10881: Impact of Successive Glycated Hemoglobin Level on Cardiovascular Events in Patients With Type 2 DiabetesTakeshi Morimoto, Yoshihiko Saito, Hisao Ogawa et al.|Circulation|2013Cited by 0